# Filana Therapeutics, Inc. (FLNA)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/FLNA/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 0 | $ -18.93M | $ -3.88M | $ 0 | $ 63.61M |
| 2025 | $ 0 | $ -93.15M | $ -28.55M | $ 0 | $ 74.40M |
| 2024 | $ 0 | $ -58.38M | $ -83.70M | $ 0 | $ 145.70M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.00 |
| Liabilities / Eq | 0.63 |
| Current Ratio | 2.08 |

## Other views

- [Metrics](https://sponda.capital/en/FLNA.md)
- [Charts](https://sponda.capital/en/FLNA/charts.md)
- [Compare](https://sponda.capital/en/FLNA/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.